Compare KYMR & WH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KYMR | WH |
|---|---|---|
| Founded | 2015 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 6.5B |
| IPO Year | 2020 | 2017 |
| Metric | KYMR | WH |
|---|---|---|
| Price | $84.99 | $85.55 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 26 | 10 |
| Target Price | ★ $107.72 | $94.10 |
| AVG Volume (30 Days) | 507.7K | ★ 1.1M |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.99% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.50 |
| Revenue | $39,211,000.00 | ★ $1,429,000,000.00 |
| Revenue This Year | $10.61 | $6.86 |
| Revenue Next Year | $8.17 | $5.83 |
| P/E Ratio | ★ N/A | $34.42 |
| Revenue Growth | N/A | ★ 1.49 |
| 52 Week Low | $28.06 | $69.21 |
| 52 Week High | $103.00 | $92.69 |
| Indicator | KYMR | WH |
|---|---|---|
| Relative Strength Index (RSI) | 48.45 | 54.69 |
| Support Level | $77.78 | $85.39 |
| Resistance Level | $90.15 | $88.34 |
| Average True Range (ATR) | 3.06 | 2.32 |
| MACD | -0.18 | -0.15 |
| Stochastic Oscillator | 29.50 | 51.27 |
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
As of Dec. 31, 2025, Wyndham Hotels & Resorts operates 869,000 rooms across more than 20 brands predominantly in the economy and midscale segments. Ramada is the largest brand, representing around 14% of all rooms, with Days Inn (13%) and Super 8 (10%) the next two largest brands, as of the end of 2025. During the past several years, the company has expanded its extended stay/lifestyle brands, which appeal to travelers seeking to experience the local culture of a given location. The company closed its La Quinta acquisition in the second quarter of 2018, adding around 90,000 rooms at the time the deal closed. Wyndham launched a new extended stay economy scale segment concept, ECHO, in the spring of 2022. The United States represented 58% of total rooms in 2025.